These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 33959876)

  • 1. Correction to: Environmental Integrants Affecting the Spreadability of SARS‑CoV‑2.
    Islam MT
    Food Environ Virol; 2021 Jun; 13(2):281. PubMed ID: 33959876
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq value.
    Sonnleitner ST; Dorighi J; Jansen B; Schönegger C; Gietl S; Koblmüller S; Sturmbauer C; Posch W; Walder G
    Virol J; 2021 Apr; 18(1):82. PubMed ID: 33879217
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.
    Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Karteris E; Kyrou I
    Mol Med Rep; 2020 Nov; 22(5):4221-4226. PubMed ID: 33000221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Smoking habits correlate with the defense against SARS‑CoV‑2 infection in the Indian population.
    Purohit B; Panda AK
    Hum Cell; 2021 Jul; 34(4):1285. PubMed ID: 34081295
    [No Abstract]   [Full Text] [Related]  

  • 5. Correction to: Poor sensitivity of "AccuPower SARS‑CoV‑2 real time RT‑PCR kit (Bioneer, South Korea)".
    Freire-Paspuel B; Garcia-Bereguiain MA
    Virol J; 2021 Feb; 18(1):41. PubMed ID: 33602239
    [No Abstract]   [Full Text] [Related]  

  • 6. The quantitative analysis of spreadability, coverage, and adhesion effect after application of the base make-up product.
    Lee SY; Baek JH; Shin MK; Koh JS
    Skin Res Technol; 2014 Aug; 20(3):341-6. PubMed ID: 24329816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of spreadability of nonaqueous ethylcellulose gel matrices using dynamic contact angle.
    Chow KT; Chan LW; Heng PW
    J Pharm Sci; 2008 Aug; 97(8):3467-82. PubMed ID: 17969118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spreading properties of cosmetic emollients: Use of synthetic skin surface to elucidate structural effect.
    Douguet M; Picard C; Savary G; Merlaud F; Loubat-Bouleuc N; Grisel M
    Colloids Surf B Biointerfaces; 2017 Jun; 154():307-314. PubMed ID: 28371727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Detection of SARS‑CoV‑2 variants in India from UK returnees.
    Potdar V; Vipat V; Jadhav S; Saha U; Jadhav SY; Bhardwaj S; Choudhary ML; Cherian S; Abraham P
    Infection; 2021 Dec; 49(6):1361. PubMed ID: 34331264
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction to: Human Stem Cell Models of SARS‑CoV‑2 Infection in the Cardiovascular System.
    Ernzen K; Trask AJ; Peeples ME; Garg V; Zhao MT
    Stem Cell Rev Rep; 2021 Dec; 17(6):2368. PubMed ID: 34677819
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections.
    Ferrara F; Vitiello A
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):117-118. PubMed ID: 34738150
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction to: A rapid and low‑cost protocol for the detection of B.1.1.7 lineage of SARS‑CoV‑2 by using SYBR Green‑based RT‑qPCR.
    Abdel Sater F; Younes M; Nassar H; Nguewa P; Hamze K
    Mol Biol Rep; 2022 Apr; 49(4):3365. PubMed ID: 34977991
    [No Abstract]   [Full Text] [Related]  

  • 13. Correction to: Short‑ and mid‑term multidisciplinary outcomes of newborns exposed to SARS‑CoV‑2 in utero or during the perinatal period: preliminary findings.
    Buonsenso D; Costa S; Giordano L; Priolo F; Colonna AT; Morini S; Sbarbati M; Pata D; Acampora A; Conti G; Crudo F; Cantiani A; Martina BM; Amorelli GM; Orazi L; Petrianni M; Ricci D; Lanzone A; Sanguinetti M; Cattani P; Sali M; Romeo D; Zampino G; Vento G; Valentini P
    Eur J Pediatr; 2022 Apr; 181(4):1521-1522. PubMed ID: 35099636
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear Integrants of Organellar DNA Contribute to Genome Structure and Evolution in Plants.
    Zhang GJ; Dong R; Lan LN; Li SF; Gao WJ; Niu HX
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: Mitochondrial Dynamics in SARS‑COV2 Spike Protein Treated Human Microglia: Implications for Neuro‑COVID.
    Clough E; Inigo J; Chandra D; Chaves L; Reynolds JL; Aalinkeel R; Schwartz SA; Khmaladze A; Mahajan SD
    J Neuroimmune Pharmacol; 2022 Dec; 17(3-4):380. PubMed ID: 34894349
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients.
    Lee J; Kim AR; Kang SW; Chang E; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Kim SH
    Clin Exp Med; 2023 Oct; 23(6):2265. PubMed ID: 36745309
    [No Abstract]   [Full Text] [Related]  

  • 17. Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study.
    Dal Ferro M; Bussani R; Paldino A; Nuzzi V; Collesi C; Zentilin L; Schneider E; Correa R; Silvestri F; Zacchigna S; Giacca M; Metra M; Merlo M; Sinagra G
    Clin Res Cardiol; 2021 Oct; 110(10):1694. PubMed ID: 34398286
    [No Abstract]   [Full Text] [Related]  

  • 18. Author Correction: Symptoms and quality of life before, during, and after a SARS‑CoV‑2 PCR positive or negative test: data from Lifelines.
    Goërtz YMJ; Spruit MA; Van Herck M; Dukers-Muijrers N; ; van der Kallen CJH; Burtin C; Janssen DJA
    Sci Rep; 2024 Apr; 14(1):8390. PubMed ID: 38600153
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against SARS-CoV-2.
    Łodyga M; Maciejewska K; Eder P; Waszak K; Stawczyk-Eder K; Michalak M; Dobrowolska A; Wiśniewska-Jarosińska M; Gąsiorowska A; Cicha M; Wierzba W; Rydzewska G
    Pol Arch Intern Med; 2021 Mar; 131(3):226-232. PubMed ID: 33544564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019.
    Kosmaczewska A; Frydecka I
    Pol Arch Intern Med; 2020 Sep; 130(9):779-788. PubMed ID: 32627515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.